French pharma giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious COVID-19 cases had proved inconclusive and it was halting the trial.
Sep 1, 2020
0
12
Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus epidemic.
Jul 31, 2020
0
13
(HealthDay)—Nirsevimab prevents respiratory syncytial virus (RSV)-associated lower respiratory tract infections in healthy preterm infants, while maternal RSV fusion (F) protein nanoparticle vaccination did not meet the ...
Jul 30, 2020
0
2
Pharma giants Sanofi and GSK said Wednesday they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine.
Jul 29, 2020
0
17
French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if studies show it can safely to be used to ...
Apr 10, 2020
0
3
French pharmaceutical firm Sanofi said Tuesday it is partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to find better treatments.
Jun 18, 2019
0
4
French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU.
Apr 26, 2019
0
170
The Philippine government said Friday it would file criminal charges against six officials of the French pharmaceutical firm Sanofi Pasteur over the deaths of children injected with its Dengvaxia anti-dengue vaccine.
Mar 1, 2019
0
4265
The World Health Organization says the first-ever vaccine for dengue needs to be dealt with in "a much safer way," meaning that the shot should mostly be given to people who have previously been infected with the disease.
Apr 19, 2018
0
0
US private equity firm Advent International has agreed to acquire Zentiva, French pharmaceutical giant Sanofi's European generics arm, for 1.9 billion euros ($2.4 billion), a statement said Tuesday.
Apr 17, 2018
0
4
